Delivery Order SPE2DB20D7066-SPE2DB25FC2GV

Award Date 2/12/25
Potential Completion Date 2/13/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,699.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor, for the delivery of Atomoxetine HCL 40 mg capsules. The contract has a completion date of February 13, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
This contract award, valued at $2,080.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of Atomoxetine HCL 40 mg capsules, and does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,342.24 delivery order is for the supply of 4,563,501,236 units of Atomoxetine HCL 25 mg capsules. The order is placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,090.83, is for the delivery of 4564513416 - Atomoxetine HCL 40 mg capsules in 30-count packages. The award has a completion date of May 7, 2024, and it is structured as a Firm Fixed Price Delivery Order contract. This contract is not designated with any set-aside requirements, indicating it...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Atomoxetine HCL 10 mg capsules. The contract has a potential value of $1,721.75 and a completion date of February 2, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,332.93 firm fixed-price delivery order is for the supply of 4566771107 - Atomoxetine HCL 40 mg capsules in quantities of 30s. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award is for the delivery of 4,566,770,990 units of the medication Atomoxetine HCL 40 mg capsules. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $2,727.36 and is a firm fixed-price delivery order with a completion date of December 20, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,560,986,377 units of Atomoxetine HCL 100 mg capsules. The $1,227.31 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a completion date of May 19, 2023. The contract is not designated as a set-aside award. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of Atomoxetine HCl 10 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract has a firm fixed price structure, a potential value of $1,626.20, and a completion date of February 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery...
This is a delivery order (SPE2DB24D6039|SPE2DB24FLDWY) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,291 units of 80 mg Atomoxetine HCL capsules. The $1,006.68 firm fixed-price contract has a completion date of July 31, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of critical medical commodities, including prescription drugs,...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB25FC2GV
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,547.45 firm fixed-price delivery order is for the supply of 4,567,240,539 units of Atomoxetine HCL 40 mg capsules. The contract has an ultimate completion date of February 13, 2025.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order falls under that broader IDC framework. The contract does not have a set-aside designation, indicating open competition.

Generated 5/14/25, 10:08 AM